Abbott Laboratories / Biocompatibles International plc (cardiovascular stent business)
2002 · Acquisition/Merger · $235M · Complete
Announcement Sentiment
80
Strongly positive
Announced March 18, 2002, Abbott Laboratories acquired the cardiovascular stent business of Biocompatibles International plc for approximately $235 million in cash. The FTC granted early termination of the antitrust waiting period on June 26, 2002.